Cargando…
Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)
Tamoxifen has been prescribed to millions of females for breast cancer prevention or treatment. However, tamoxifen is known to significantly enhance the risk of developing endometrial lesions, including hyperplasia, polyps, carcinomas, and sarcoma. Notably, tamoxifen-associated endometrial cancer of...
Autores principales: | HU, RONG, HILAKIVI-CLARKE, LEENA, CLARKE, ROBERT |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356269/ https://www.ncbi.nlm.nih.gov/pubmed/25788989 http://dx.doi.org/10.3892/ol.2015.2962 |
Ejemplares similares
-
Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model
por: De Oliveira Andrade, Fabia, et al.
Publicado: (2019) -
Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor
por: Li, Ye, et al.
Publicado: (2021) -
Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters
por: Hilakivi-Clarke, Leena
Publicado: (2014) -
Birth weight in relation to endometrial and breast cancer risks in Swedish women
por: Löf, M, et al.
Publicado: (2007) -
Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
por: Saeki, Harumi, et al.
Publicado: (2023)